Jing Xu
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 6
- Cellular transport and secretion 5
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- Molecular Biology top 5%
- Physiology top 5%
- Physiology top 5%
-
- Lung Cancer Treatments and Mutations 8
-
- COVID-19 Clinical Research Studies 6
-
- Cancer-related Molecular Pathways 5
-
- Hemoglobinopathies and Related Disorders 5
- Genomics and Rare Diseases 4
Jing Xu
135 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Cell Biology 436
- Cancer Research 373
- Molecular Biology 1.7k
- Physiology 110
- Physiology 626
Countries citing papers authored by Jing Xu
This map shows the geographic impact of Jing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Xu more than expected).
Fields of papers citing papers by Jing Xu
This network shows the impact of papers produced by Jing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Xu. The network helps show where Jing Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 22 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 33 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 80 | |
| 17 | 2020 | 9 | |
| 18 | 2017 | 68 | |
| 19 | 2015 | 78 | |
| 20 | 2007 | 19 |
About Jing Xu
Jing Xu is a scholar working on Oncology, Genetics and General Energy, having authored 152 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers), COVID-19 Clinical Research Studies (6 papers), Cancer-related Molecular Pathways (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Cellular transport and secretion (5 papers), Genomics and Rare Diseases (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cell Biology (436 citations), Cancer Research (373 citations) and Molecular Biology (1.7k citations). Jing Xu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Jun O. Liu, Yongjun Dang, Zhibiao Wang, Yunzhao R. Ren, Chenglai Fu, Solomon H. Snyder, Curtis R. Chong, Luis F. Parada, Feng Rao and Shridhar Bhat. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.